The expression of antiapoptotic proteins Bcl-2, Bcl-xL, and Mcl-1 in benign, dysplastic, and malignant biliary epithelium

Journal of Clinical Pathology

Volumn 54, Issue 12, 2001, Pages 927-932

  Okaro, A C ^a   Deery, A R ^a   Hutchins, R R ^a   Davidson, B R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Cholangiocarcinoma; Mcl 2

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS INHIBITOR; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN MCL 1;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER INVASION; CELL GRANULE; CELL SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG PROTEIN BINDING; DYSPLASIA; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 0035675874     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.12.927     Document Type: Article

References (38)

1. Mechanisms of biliary carcinogenesis: A pathogenetic multi-stage cascade towards cholangiocarcinoma
2. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan
3. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: Predictors of outcomes
4. Surgical treatment of cholangiocellular carcinoma
5. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors
6. Resection of intrahepatic cholangiocarcinoma: A Western experience
7. Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts
8. Klatskin tumours: A 20 year experience
9. Phase II trial of docetaxel for cholangiocarcinoma
10. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
11. Intraluminal brachytherapy in the treatment of bile duct carcinomas
12. Intraoperafive radiotherapy for unresectable cholangiocarcinoma-the Mayo Clinic experience
13. Apoptosis and the dilemma of cancer chemotherapy
14. Avoidance of apoptosis as a mechanism of drug resistance
15. Bcl-2 gene family in the nervous system
16. The Bcl-2 protein family: Arbiters of cell survival
17. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
18. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
19. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
20. Mitochondria and apoptosis
21. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
22. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver
23. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line
24. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions
25. Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck
26. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse
27. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
28. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells
29. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis
30. Bcl-XL protects cancer cells from p53-mediated apoptosis
31. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
32. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
33. Biliary adenocarcinoma. Characterisation of three new human tumor cell lines
34. Establishment of a new extrahepatic bile duct carcinoma cell line, TFK- 1
35. An enhanced immunocytochemical method for staining bone marrow trephine sections
36. p53 but not bcl-2 is expressed by most cholangiocarcinomas: A study of 28 cases
37. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver
38. Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli